Menin deficiency in high-fat diet (HFD) models leads to hepatic steatosis, while menin overexpression reduces triglyceride accumulation, suggesting the menin-SIRT1 axis as a potential therapeutic target for hepatic steatosis and age-related metabolic disorders (Cao et al., 2013). The gene discussed is MEN1; the disease is Other metabolic disease.